Granulocyte-colony stimulating factor for hematopoietic stem cell donation from healthy female donors during pregnancy and lactation: What do we know?

Human Reproduction Update

Volumn 19, Issue 3, 2013, Pages 259-267

  Pessach, Ilias ^a   Shimoni, Avichai ^a   Nagler, Arnon ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Granulocyte colony stimulating factor; Lactation; Pregnancy; Stem cell transplantation

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IDARUBICIN; PEGYLATED BOVINE GRANULOCYTE COLONY STIMULATING FACTOR; PLACEBO; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANESTHESIA; ARTICLE; BONE MARROW BIOPSY; BREAST FEEDING; CANCER RISK; CELL GROWTH; CONGENITAL MALFORMATION; DONOR; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; EMBRYO TRANSFER; EMBRYOPATHY; FEMALE; FETUS DEATH; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; GRANULOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; LACTATION; LEUKEMIA; MEDICAL LITERATURE; MEDLINE; METABOLISM; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; NEWBORN MORTALITY; NIDATION; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PLACENTA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREIMPLANTATION EMBRYO; PREMATURITY; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECOND TRIMESTER PREGNANCY; SEVERE CONGENITAL NEUTROPENIA; SIDE EFFECT; SPONTANEOUS ABORTION; STEM CELL MOBILIZATION; SYSTEMATIC REVIEW; TERATOGENICITY; THIRD TRIMESTER PREGNANCY; TROPHOBLAST;

ANIMALS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LACTATION; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84876813263     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dms053     Document Type: Article

References (63)

1. Abe T, Azuma H, Watanabe A, Shigekiyo T, Endou S, Pou R, Fukui R, Maeda K, Aono T, Matsumoto T. A patient with cyclic neutropenia complicated by severe persistent neutropenia successfully delivered a healthy baby. Intern Med 2000;39:663-666.
2. Achtari C, Hohlfeld P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am J Obstet Oncol 2000;183:511-512.
3. Ahmad A, Laborada G, Bussel J, Nesin M. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte macrophage colony-stimulating factor and placebo for treatment of septic preterm infants. Pediatr Infect Dis J 2002;21:1061-1065.
4. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004;5:266-271.
5. Anderlini P, Chan FA, Champlin RE, Körbling M, Strom SS. Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development. Bone Marrow Transplant 2002;30:661-663.
6. Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2001;2:173-177.
7. Bennett CL, Evens AM, Andritsos LA, Balasubramanian L, Mai M, Fisher MJ, Kuzel TM, Angelotta C, McKoy JM, Vose JM et al. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol 2006;135:642-650.
8. Brewer M, Kueck A, Runowicz CD. Chemotherapy in pregnancy. Clin Obstet Gynecol. 2011;54:602-618.
9. Calder C, Hays SR, Manes B, Lavin VA, Ho RH, Frangoul H. Successful bone marrow harvest during pregnancy. Bone Marrow Transplant 2005;35:631-632.
10. Calhoun DA, Christensen RD. A randomized pilot trial of administration of granulocyte colony-stimulating factor to women before preterm delivery. Am J Obstet Gynecol 1998;179:766-771.
11. Cavallaro AM, Lilleby K, Majolino I, Storb R, Appelbaum FR, Rowley SD, Bensinger WI. Three to six year follow up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 2000;25:85-89.
12. Cavenagh JD, Richardson DS, Cahill MR, Bernard T, Kelsey SM, Newland AC. Treatment of acute myeloid leukaemia in pregnancy. Lancet 1995;346:441-442.
13. Claahsen HL, Semmekrot BA, Van Dongen PWJ, Mattijssen V. Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy: a case report. Am J Perinatol 1998;15:295-297.
14. Cohen AM, Zsebo KM, Inoue H, Hines D, Boone TC, Chazin VR, Tsai L, Ritch T, Souza LM. In vivo stimulation of granulopoiesis by recombinant granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 1987;84:2484-2488.
15. Cottle TE, Fier CJ, Donadieu J, Kinsey SE. Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor. Semin Hematol 2002;39:134-140.
16. Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Freedman MH, Kannourakis G, Kinsey SE et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003;72:82-93.
17. Donadieu J, Leblanc T, Bader Meunier B, Barkaoui M, Fenneteau O, Bertrand Y, Maier-Redelsperger M, Micheau M, Stephan JL, Phillipe N et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia: experience of the French Severe Chronic Neutropenia Study Group. Haematologica 2005;90:45-53.
18. European Public MRL Assessment Report (EPMAR). Pegylated bovine granulocyte colony stimulating factor (PEGbG-CSF) (bovine species). EMA/CVMP/190918/ 2010. Committee for Medicinal Products for Veterinary Use, 9 March 2012.
19. Funke A, Berner R, Traichel B, Schmeisser D, Leititis JU, Niemeyer CM. Frequency, natural course, and outcome of neonatal neutropenia. Pediatrics 2000; 106:45-51.
20. Halter J, Kodera Y, Ispizua AU, Greinix HT, Schmitz N, Favre G, Baldomero H, Niederwieser D, Apperley JF, Gratwohl A. Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica 2009;94:94-101.
21. Kaida K, Ikegame K, Fujioka T, Taniguchi Y, Inoue T, Hasei H, Tamaki H, Yoshihara S, Kawase I, Ogawa H. Kinetics of granulocyte colony-stimulating factor in the human milk of a nursing donor receiving treatment for mobilization of the peripheral blood stem cells. Acta Haematol 2007;118:176-177.
22. Kaplinsky C, Trakhtenbrot L, Hardan I, Reichart M, Daniely M, Toren A, Amariglio N, Rechavi G, Izraeli S. Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF. Bone Marrow Transplant 2003;32:31-34.
23. Kato Y, Kuwabara T, Itoh T, Hiura M, Hatori A, Shigematsu A, Hara T. A possible relationship between abortions and placental embolism in pregnant rabbits given human granulocyte colony-stimulating factor. J Toxicol Sci 2001; 26:39-50.
24. Kaufmann SJ, Sharif K, Sharma V, McVerry BA. Term delivery in a woman with severe congenital neutropenia treated with growth colony stimulating factor. Hum Reprod 1998;13:498-499.
25. Keller P, Smalling R. Granulocyte colony stimulating factor: animal studies for risk assessment. Int Rev Exp Pathol 1993;34:173-88.
26. Kotto-Kome AC, Fox SE, Lu W, Yang BB, Christensen RD, Calhoun DA. Evidence that the granulocyte colony-stimulating factor (G-CSF) receptor plays a role in the pharmacokinetics of G-CSF and PegG-CSF using a G-CSF-R KO model. Pharmacol Res 2004;50:55-58.
27. Kuhn P, Messer J, Paupe A, Espagne S, Kacet N, Mouchnino G, Klosowski S, Krim G, Lescure S, Le Bouedec S et al. A multicenter, randomized, placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia. J Pediatr 2009;155:324-330.
28. Leitner G, Loidolt H, Greinix HT, Höcker P, Dettke M. Granulocyte colony-stimulating factor-induced allogeneic peripheral stem cell donation during early pregnancy. Br J Haematol 2001;115:233-234.
29. Lewis RM, Cleal JK, Hanson MA. Placenta, evolution and lifelong health. Placenta 2012;33:28-32.
30. Lin C-P, Huang M-J, Liu H-J, Chang IY, Tsai C-H. Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah's Witness with all-trans retinoic acid, rhGCSF, and erythropoietin. Am J Hematol 1996;51:251-252.
31. Litwin S, Lagadari M, Barrientos G, Roux ME, Margni R, Miranda S. Comparative immunohistochemical study of M-CSF and G-CSF in feto-maternal interface in a multiparity mouse model. Am J Reprod Immunol 2005;54:311-320.
32. McCracken S, Layton JE, Shorter SC, Starkey PM, Barlow DH, Mardon HJ. Expression of granulocyte-colony stimulating factor and its receptor is regulated during the development of the human placenta. J Endocrinol 1996; 149:249-258.
33. McCracken SA, Grant KE, MacKenzie IZ, Redman CW, Mardon HJ. Gestational regulation of granulocyte-colony stimulating factor receptor expression in the human placenta. Biol Reprod 1999;60:790-796.
34. Medlock ES, Kaplan DL, Cecchini M, Ulich TR, Castillo J, Andresen J. Granulocyte colony-stimulating factor crosses the placenta and stimulates fetal rat granulopoiesis. Blood 1993;81:916-922.
35. Moldenhauer LM, Diener KR, Thring DM, Brown MP, Hayball JD, Robertson SA. Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy. J Immunol 2009; 182:8080-8093.
36. Molloy EJ, O'Neill AJ, Grantham JJ, Sheridan-Pereira M, Fitzpatrick JM, Webb DW, Watson RWG. Granulocyte colony-stimulating factor and granulocytemacrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function. Pediatr Res 2005;57:806-812.
37. Nagler A, Toren A, Samuel S. Effect of granulocyte colony stimulating factor (G-CFS) administration for stem cell mobilization on temporal order of allelic replication. Blood 1999;94:605a.
38. Nagler A, Korenstein-Ilan A, Amiel A, Avivi L. Granulocyte colony stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells. Exp Hematol 2004;32:122-130.
39. Niedermeier DM, Frei-Lahr DA, Hall PD. Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy. Pharmacotherapy 2005; 25:1134-1140.
40. Novales JS, Salva AM, Modanlou HD, Kaplan DL, Castillo J, Andresen J, Medlock ES. Maternal administration of granulocyte colony-stimulating factor improves neonatal rat survival after a lethal group B streptococcal infection. Blood 1993; 81:923-926.
41. Okasaki K, Funato M, Kashima M, Nakama K, Inoue T, Hiura M, Kato Y, Nagata R. Twenty-six-week repeat-dose toxicity study of a recombinant human granulocyte colony-stimulating factor derivative (nartograstim) in cynomolgus monkeys. Toxicol Sci 2002;65:246-255.
42. O'Neill C. The potential roles for embryotrophic ligands in preimplantation embryo development. Hum Reprod Update 2008;14:275-288.
43. Pollheimer J, Knöfler M. The role of the invasive, placental trophoblast in human pregnancy. Wien Med Wochenschr 2012;162:187-190.
44. Pulsipher MA, Nagler A, Iannone R, Nelson RM. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr Blood Cancer 2006;46:422-433.
45. Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood 2009;113:3604-3611.
46. Reynoso EE, Huerta F. Acute leukemia and pregnancy: fatal fetal outcome after exposure to idarubicin during the second trimester. Acta Oncol 1994; 33:703-716.
47. Reynoso EE, Shepherd FA, Messner HA, Farquharson HA, Garvey MB, Baker MA. Acute leukemia during pregnancy: the Toronto leukemia study group experience with long-term follow-up of children exposed to in utero chemotherapeutic agents. J Clin Oncol 1987;5:1098-1106.
48. Robertson SA, Mayrhofer G, Seamark RF. Uterine epithelial cells synthesize granulocyte-macrophage colony-stimulating factor and interleukin-6 in pregnant and nonpregnant mice. Biol Reprod 1992;46:1069-1079.
49. Robertson SA, Mau VJ, Tremellen KP, Seamark RF. Role of high molecular weight seminal vesicle proteins in eliciting the uterine inflammatory response to semen in mice. J Reprod Fertil 1996;107:265-277.
50. Robertson SA, Sjoblom C, Jasper MJ, Norman RJ, Seamark RF. Granulocyte-macrophage colony-stimulating factor promotes glucose transport and blastomere viability in murine preimplantation embryos. Biol Reprod 2001; 64:1206-1215.
51. Robertson SA, Guerin LR, Bromfield JJ, Branson KM, Ahlström AC, Care SA. Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol Reprod 2009; 80:1036-1045.
52. Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Fier C, Freedman M, Kannourakis G, Kinsey S et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006;07:4628-4635.
53. Sangalli MR, Peek M, McDonald A. Prophylactic granulocyte colony-stimulating factor treatment for acquired chronic severe neutropenia in pregnancy. Aust NZJ Obstet Gynaecol2001;41:470-471.
54. Scarpellini F, Sbracia F. Use of colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod 2009;11:2703-2708.
55. Shapira MY, Kaspler P, Samuel S, Shoshan S, Or R. Granulocyte colony stimulating factor does not induce long-term DNA instability in healthy peripheral blood stem cell donors. Am J Hematol 2003;73:33-36
56. Shaw BE, Confer DL, Hwang WY, Pamphilon DH, Pulsipher MA. Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association. Haematologica 2011;96:942-947.
57. Shibata H, Yamane T, Aoyama Y, Nakamae H, Hasegawa T, Sakamoto C, Terada Y, Koh G, Hino M. Excretion of granulocyte colony-stimulating factor into human breast milk. Acta Haematol 2003;110:200-201.
58. Siu BL, Alonzo MR, Vargo TA, Fenrich AL. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and alltrans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int J Gynecol Cancer 2002;12:399-402.
59. Sjoblom C, Wikland M, Robertson SA. Granulocyte-macrophage colony-stimulating factor promotes human blastocyst development in vitro. Hum Reprod 1999; 14:3069-3076.
60. Sjoblom C, Roberts CT, Wikland M, Robertson SA. Granulocyte-macrophage colony-stimulating factor alleviates adverse consequences of embryo culture on fetal growth trajectory and placental morphogenesis. Endocrinology 2005;146:2142-2153.
61. Ulich TR, Del Castillo J, Guo K, Souza L. Kinetics and mechanisms of recombinant human granulocyte colony-stimulating factor induced neutrophilia. Am J Pathol 1988;133:638.
62. Uzumaki H, Okabe T, Sasaki N, Hagiwara K, Takaku F, Tobita M, Yasukawa K, Ito S, Umezawa Y. Identification and characterization of receptors for granulocyte colony-stimulating factor on human placenta and trophoblastic cells. Proc Natl Acad Sci USA 1989;86:9323-9326
63. Zsebo KM, Cohen AM, Murdock DC, Boone TC, Inoue H, Chazin VR, Hines D, Souza LM. Recombinant human granulocyte colony stimulating factor:molecular and biological characterization. Immunobiology 1986;172:175-184.